Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed)

Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media

(2012) Robert Cohen et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

(2011) T.F. Schwarz et al.   VACCINE

Determining the Optimal Pneumococcal Vaccination Strategy for Adults

(2010) Mark L. Metersky et al.   CHEST

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

(2010) Mark H. Rozenbaum et al.   CLINICAL THERAPEUTICS

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

(2010) Sean T. Duggan   DRUGS

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults

(2010) Neil French et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Pathogenesis, treatment, and prevention of pneumococcal pneumonia

(2009) Tom van der Poll et al.   LANCET

Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection

(2008) Lisa A. Jackson et al.   CLINICAL INFECTIOUS DISEASES